|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61P 9/04 | |||
| A61P 9/10 |
| (11) | Number of the document | 2555788 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11760220.1 |
| Date of filing the European patent application | 2011-03-24 | |
| (97) | Date of publication of the European application | 2013-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/029799 |
| Date | 2011-03-24 |
| (87) | Number | WO 2011/119836 |
| Date | 2011-09-29 |
| (30) | Number | Date | Country code |
| 317094 P | 2010-03-24 | US |
| (72) |
JAY, Steven, M., US
GRIFFITH, Linda, G., US
LEE, Richard, T., US
|
| (73) |
Massachusetts Institute of Technology,
77 Massachusetts Avenue, Cambridge, MA 02139,
US
The Brigham and Women`s Hospital, Inc., 75 Francis Street, Boston, MA 02115, US |
| (54) | NEUREGULIN DIMER FOR AN ErbB/HER RECEPTOR FOR USE IN REDUCING CARDIOTOXICITY. |
| NEUREGULIN DIMER FOR AN ErbB/HER RECEPTOR FOR USE IN REDUCING CARDIOTOXICITY. |